Marie-Pierre Dube,Eric J. Niesor,Jean-Claude Tardif,Ruchi Upmanyu
申请号：
US16109447
公开号：
US10711303B2
申请日:
2018.08.22
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator.
